Cidara Therapeutics, Inc.

Contributing Author

Recent Articles by Cidara Therapeutics, Inc.

Jun-24	Cidara Announces Pricing of Upsized Public Offering of Common Stock CDTX GlobeNewswire
Jun-23	Cidara Announces Proposed Public Offering of Common Stock CDTX GlobeNewswire
Jun-23	Cidara Therapeutics Announces Positive Topline Results from its Phase 2b NAVIGATE Trial Evaluating CD388, a Non-Vaccine Preventative of Seasonal Influenza CDTX GlobeNewswire
May-15	Cidara Therapeutics to Host Virtual R&D Day to Discuss CD388 as a Potential Universal, Once-Per-Flu Season Preventative of Seasonal and Pandemic Influenza on May 22, 2025 CDTX GlobeNewswire
May-13	Cidara Therapeutics to Participate in Two Upcoming Investor Conferences CDTX GlobeNewswire
May-08	Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results CDTX GlobeNewswire
May-01	Cidara Therapeutics Announces Promotion of Nicole Davarpanah to Chief Medical Officer and Corrina Pavetto to SVP, Clinical Development CDTX GlobeNewswire